NO161493C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater.

Info

Publication number
NO161493C
NO161493C NO853329A NO853329A NO161493C NO 161493 C NO161493 C NO 161493C NO 853329 A NO853329 A NO 853329A NO 853329 A NO853329 A NO 853329A NO 161493 C NO161493 C NO 161493C
Authority
NO
Norway
Prior art keywords
chained
straight
carbon atoms
branched alkyl
naphthyridine derivatives
Prior art date
Application number
NO853329A
Other languages
English (en)
Other versions
NO161493B (no
NO853329L (no
Inventor
Gerhard Satzinger
Johannes Hartenstein
Karl Mannhardt
Juergen Kleinschroth
Hartmut Osswald
Guenther Weinheimer
Edgar Fritschi
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843431303 external-priority patent/DE3431303A1/de
Priority claimed from DE19853502790 external-priority patent/DE3502790A1/de
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of NO853329L publication Critical patent/NO853329L/no
Publication of NO161493B publication Critical patent/NO161493B/no
Publication of NO161493C publication Critical patent/NO161493C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO853329A 1984-08-25 1985-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater. NO161493C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843431303 DE3431303A1 (de) 1984-08-25 1984-08-25 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
DE19853502790 DE3502790A1 (de) 1985-01-29 1985-01-29 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung

Publications (3)

Publication Number Publication Date
NO853329L NO853329L (no) 1986-02-26
NO161493B NO161493B (no) 1989-05-16
NO161493C true NO161493C (no) 1989-08-23

Family

ID=25824189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853329A NO161493C (no) 1984-08-25 1985-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater.

Country Status (22)

Country Link
US (1) US4711901A (no)
EP (1) EP0173933B1 (no)
KR (1) KR890000706B1 (no)
AT (1) ATE48276T1 (no)
AU (1) AU576887B2 (no)
BG (1) BG43691A3 (no)
CA (1) CA1263118A (no)
DE (1) DE3574471D1 (no)
DK (1) DK165247C (no)
ES (1) ES8604960A1 (no)
FI (1) FI80697C (no)
GR (1) GR852040B (no)
HU (1) HU194879B (no)
IE (1) IE58364B1 (no)
IL (2) IL75987A (no)
NO (1) NO161493C (no)
NZ (1) NZ213218A (no)
PH (4) PH21177A (no)
PL (1) PL146668B1 (no)
RO (1) RO92245B (no)
SU (1) SU1395143A3 (no)
YU (2) YU45000B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431303A1 (de) * 1984-08-25 1986-02-27 Goedecke Ag 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
DE3906460C1 (no) * 1989-03-01 1990-11-15 Goedecke Ag, 1000 Berlin, De
DE3906406C1 (no) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
DE102006026583A1 (de) 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
DE102006026585A1 (de) 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
DE102007009494A1 (de) 2007-02-27 2008-08-28 Bayer Healthcare Ag Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
AU2015295376C1 (en) * 2014-08-01 2020-07-16 Bayer Pharma Aktiengesellschaft Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
CN107849043B (zh) * 2015-08-21 2020-10-16 拜耳制药股份公司 用于制备(4s)-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-甲酰胺的方法
PE20180555A1 (es) * 2015-08-21 2018-04-02 Bayer Pharma AG Procedimiento para la preparacion de (4s)-4-(4-ciano-2-metoxifenilo)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridina-3-carboxamida y para la recuperacion de (4s)-4-(4-ciano-2-metoxifenilo)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridina-3-carboxamida por medio de metodos electroquimicos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304914A (en) * 1980-07-07 1981-12-08 Usv Pharmaceutical Corporation Naphthyridone derivatives
DE3327650A1 (de) * 1983-07-30 1985-02-14 Gödecke AG, 1000 Berlin 1,6-naphthyridinon-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von gefaesserkrankungen

Also Published As

Publication number Publication date
YU14588A (en) 1991-02-28
NO161493B (no) 1989-05-16
YU134885A (en) 1988-10-31
ES8604960A1 (es) 1986-03-01
IL75987A (en) 1991-07-18
IL75987A0 (en) 1985-12-31
SU1395143A3 (ru) 1988-05-07
YU47010B (sh) 1994-11-15
IE852085L (en) 1986-02-25
EP0173933B1 (de) 1989-11-29
RO92245B (ro) 1987-07-31
GR852040B (no) 1985-12-19
PH24762A (en) 1990-10-01
PH21177A (en) 1987-08-07
CA1263118A (en) 1989-11-21
ATE48276T1 (de) 1989-12-15
KR890000706B1 (ko) 1989-03-27
DE3574471D1 (de) 1990-01-04
PH23411A (en) 1989-07-26
DK384485A (da) 1986-02-26
RO92245A (ro) 1987-07-30
IE58364B1 (en) 1993-09-08
BG43691A3 (en) 1988-07-15
KR860001810A (ko) 1986-03-22
US4711901A (en) 1987-12-08
PH23379A (en) 1989-07-26
DK384485D0 (da) 1985-08-23
DK165247B (da) 1992-10-26
DK165247C (da) 1993-04-26
NO853329L (no) 1986-02-26
FI80697B (fi) 1990-03-30
FI853233L (fi) 1986-02-26
FI853233A0 (fi) 1985-08-22
AU4662685A (en) 1986-02-27
EP0173933A1 (de) 1986-03-12
HUT39448A (en) 1986-09-29
NZ213218A (en) 1990-01-29
PL255118A1 (en) 1986-07-29
HU194879B (en) 1988-03-28
FI80697C (fi) 1990-07-10
YU45000B (en) 1991-06-30
AU576887B2 (en) 1988-09-08
ES546366A0 (es) 1986-03-01
PL146668B1 (en) 1989-02-28

Similar Documents

Publication Publication Date Title
ES486349A1 (es) Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas
JPS568361A (en) Pyroglutamic acid derivative and analogue
FI861410A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva aminopropanolderivat.
NO161493C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater.
NO168418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
DK163144C (da) Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf
ES453690A1 (es) Procedimiento para la preparacion de compuestos heterocicli-cos.
NO172939C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive estere av estramustin
DE3167347D1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof
DK119886A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstillingog deres anvendelse som laegemiddel
FI871253A0 (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
ES2076247T3 (es) Derivados de la pteridina farmaceuticamente eficaces.
IT1210914B (it) Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.
JPS6426553A (en) Novel derivative of 1-benzyl-2-oxo-5-alkoxy- pyrrolidine, manufacture, use as drug and composition
HK108997A (en) 1'-amino-2-(benzothiazolyl)methyl¾spiro isoquinoline-4(1H),3'-pyrrolidine¾-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors